Mental Illness

Recent scientific inquiry has unveiled compelling evidence that focused magnetic stimulation of the brain can significantly improve memory, particularly the recall of past events. This breakthrough comes from a meta-analysis, a rigorous statistical technique that synthesizes data from multiple independent studies, published in the journal eLife. The findings highlight a noninvasive method that targets a specific brain network, enhancing event-based memory without impacting other cognitive capabilities. This offers a robust foundation for advancing treatments for various memory impairments.

Episodic memory, our capacity to recollect personal experiences, relies heavily on the hippocampus and its interconnected brain regions. Disruptions within this intricate network can lead to considerable memory deficits. Transcranial Magnetic Stimulation (TMS), a noninvasive procedure, uses magnetic pulses to stimulate nerve cells in targeted superficial brain areas, thereby indirectly influencing deeper memory centers like the hippocampus. This technique, known as Hippocampal Indirectly Targeted Stimulation (HITS), was pioneered by Joel Voss and his team at the University of Chicago and has shown consistent, positive effects on memory across numerous studies, indicating a remarkable specificity in its impact on cognitive function.

Targeted Brain Stimulation and Memory Enhancement

A recent meta-analysis underscores the efficacy of noninvasive magnetic stimulation, specifically Hippocampal Indirectly Targeted Stimulation (HITS), in improving episodic memory. This technique, which involves directing magnetic pulses to brain regions that communicate with the hippocampus, has been shown to enhance the recall of personal experiences without affecting other cognitive functions. The study, combining data from 38 diverse investigations and over 1,000 participants, provides strong statistical evidence that HITS reliably boosts event-based memory, positioning it as a promising therapeutic strategy for memory disorders.

The intricate mechanism behind episodic memory involves the hippocampus and its extensive network of connections to other brain areas. When these connections are compromised, memory problems often arise. HITS circumvents the hippocampus's deep location by stimulating superficial brain regions, which then indirectly influence the deeper memory structures. Joel Voss, a professor of neurology, developed this approach, and subsequent independent research has consistently supported its effectiveness. The meta-analysis meticulously evaluated 253 statistical comparisons, demonstrating that HITS significantly improved episodic memory while showing no measurable effect on non-memory cognitive tasks such as attention, working memory, or language processing. This remarkable selectivity suggests that HITS uniquely targets memory functions, differentiating it from more generalized brain interventions.

Mechanisms of Memory Improvement and Future Implications

Further analysis revealed that HITS primarily enhances recollection—the ability to vividly recreate past events with specific details—rather than mere recognition. This distinction is crucial because recollection is highly dependent on the hippocampus and is particularly vulnerable in memory disorders like dementia. The timing of the stimulation also proved critical; applying magnetic pulses before memory tasks was far more effective than during the retention period, indicating that HITS primarily supports memory formation (encoding) rather than retention or retrieval. This precision in targeting specific memory processes and stages of memory formation highlights the potential for HITS in clinical applications.

The selective impact of HITS on recollection verifies its targeted pathway, demonstrating that the treatment directly influences hippocampus-dependent memory processes. This specificity is a significant advancement in neuroscience, as many brain interventions often yield generalized rather than specific cognitive effects. The robust and replicable nature of these findings, validated across numerous experiments and laboratories, sets HITS apart. While the meta-analysis provides a strong scientific basis for its potential, experts caution that further research is needed to determine its long-term outcomes and clinical viability for conditions like Alzheimer's disease or major depression. The safety profile, with no serious adverse events reported, adds to its promise, but extensive clinical trials are essential before HITS can be widely adopted as a medical treatment.

The 2026 James McKeen Cattell Sabbatical Award, administered by the Association for Psychological Science on behalf of the James McKeen Cattell Fund, has been conferred upon three pioneering researchers: Juliet Davidow, Jessica Magidson, and Marisa Spann. This esteemed recognition provides crucial supplementary funding to bolster their institutional sabbatical allowances for the 2026–2027 academic year. This financial support empowers these scientists to significantly broaden the scope and depth of their ongoing research endeavors. Their projects are poised to explore fundamental aspects of human development, mental health, and biological influences, promising to contribute vital new insights to the field of psychological science.

Pioneering Psychological Research: Unpacking Adolescent Learning, Nature's Therapeutic Power, and Maternal Immune Influence

In a significant announcement from the Association for Psychological Science, the 2026 James McKeen Cattell Sabbatical Awards have been granted to three exceptional researchers: Juliet Davidow, Jessica Magidson, and Marisa Spann. These prestigious awards, backed by the James McKeen Cattell Fund, are designed to enhance the sabbatical leaves of distinguished scholars, enabling them to pursue innovative research with expanded resources. The Fund, established in 1942, has a long-standing commitment to advancing psychological science and its practical applications.

Dr. Juliet Davidow, affiliated with Northeastern University, will dedicate her sabbatical to exploring the intricacies of adolescent brain development and its profound impact on motivated learning. Her research will leverage advanced structural brain imaging techniques, coupled with reinforcement learning tasks, to investigate how dopamine processes influence learning in young individuals. A particular focus will be on the potential of noninvasive iron imaging as a proxy for dopamine activity, offering new avenues for repurposing existing functional brain scan data. This work aims to provide transformative insights into adolescent neurocognitive functioning, with implications for education and mental health interventions.

Dr. Jessica Magidson from the University of Maryland, College Park, will embark on a groundbreaking project to integrate evidence-based mental health interventions with the therapeutic benefits of nature exposure. Recognizing the global unmet need for mental healthcare and increasing provider burnout, Dr. Magidson’s research posits that the natural world could be a scalable solution. Her sabbatical will involve studying international nature-based mental health programs, authoring a comprehensive review on nature-based cognitive behavioral therapy (CBT) delivery, and developing a clinician manual for nature-infused CBT. She plans to spend her sabbatical at the University of Colorado Boulder and participate in Harvard’s Nature as Medicine Practitioner Training, aiming to shift conventional practices towards a more holistic approach for both patients and practitioners.

Meanwhile, Dr. Marisa Spann of Columbia University will focus on the crucial role of maternal immune activation (MIA) in offspring neurodevelopment. Her research aims to unravel the dynamic interplay between the early immune environment and the developing brain, identifying early immune, brain, and neuropsychological markers of psychiatric risk. Collaborating with leading international research groups, Dr. Spann will explore the innovative use of deciduous 'baby' teeth as a biospecimen to understand childhood immune-related exposures. This interdisciplinary approach, combining neuroimaging, epidemiology, biospecimens, and data science, seeks to elucidate the complex relationships between maternal and offspring immune systems and their influence on early brain development.

These three diverse yet equally vital research projects underscore the enduring commitment of the James McKeen Cattell Fund to fostering groundbreaking work in psychology. The 2026 sabbatical awardees are poised to make significant contributions that could reshape our understanding of human development, mental wellness, and the intricate biological underpinnings of health.

The James McKeen Cattell Sabbatical Awards represent a crucial investment in the future of psychological science. By providing dedicated time and resources to brilliant minds like Davidow, Magidson, and Spann, the fund enables deep, focused inquiry that often yields breakthroughs. Their work is not just about academic advancement; it holds the potential for real-world impact, from informing new educational strategies for adolescents and expanding access to mental health care through innovative nature-based therapies, to understanding the earliest biological influences on a child's brain development. This foresight in supporting fundamental and applied research is commendable and essential for addressing some of humanity's most pressing challenges.